Literature DB >> 9741314

Heart involvement in systemic sclerosis: an ultrasonic tissue characterisation study.

C Ferri1, V Di Bello, A Martini, D Giorgi, F A Storino, M Bianchi, A Bertini, M Paterni, C Giusti, G Pasero.   

Abstract

BACKGROUND: Clinicoepidemiological findings indicate that symptomatic heart involvement in patients with systemic sclerosis (SSc) predicts a very poor prognosis. At necropsy studies, SSc heart involvement without significant coronary lesions is characterised by patchy myocyte necrosis and contraction band necrosis with collagen replacement leading to myocardial fibrosis. There is a discrepancy between the frequency of clinically evident myocardial disease (25%) and autoptical myocardial fibrosis (81%).
OBJECTIVE: The aim of this study was to detect preclinical myocardial alterations in SSc patients by ultrasonic videodensitometric analysis.
METHODS: Thirty five SSc patients (three male, aged 48.6 (11) SD years, range 22-65) with normal ventricular function and 25 age and sex matched healthy controls were studied. All patients had a negative maximal exercise stress; in all cases arterial hypertension, renal involvement, and diabetes were excluded. Echocardiographic images were digitised by a real time videodigitiser (Tomtec Imaging Systems). Quantitative texture analysis was performed on data from the septum and the posterior wall, obtaining mean gray level histogram (MGL) at both end-diastole (d) and end-systole (s). The cyclic variation index (CVI), was calculated according to the formula ((MGLd-MGLs)/MGLd) x 100. Left ventricular mass (LVM), body surface corrected, was calculated according to Penn convention.
RESULTS: Comparable systolic and diastolic blood pressure, LVM, diastolic and systolic function were recorded in both SSc patients and controls. In contrast, in SSc patients the CVI, which is the expression of the intrinsic myocardial structural function, was significantly lower than in controls (septum: -18 (28)% v 35 (10)%, p < 0.0001; and posterior wall: -13 (32)% v 50 (20)%, p < 0.0001). Changes in cyclic echo amplitude, probably related to myocardial fibrosis, were detected in the large majority of SSc patients (88%).
CONCLUSIONS: Ultrasonic videodensitometric analysis represents a non-invasive, feasible method that can detect early myocardial changes in SSc patients, which could be related to both fibrosis and microcirculatory abnormalities. Their potential evolution towards ventricular dysfunction and their link with cardiac sudden death, because of severe conduction system or rhythm disturbances, should be further investigated.

Entities:  

Mesh:

Year:  1998        PMID: 9741314      PMCID: PMC1752602          DOI: 10.1136/ard.57.5.296

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  40 in total

1.  De subitaneis mortibus. VIII. Coronary arteries and conduction system in scleroderma heart disease.

Authors:  T N James
Journal:  Circulation       Date:  1974-10       Impact factor: 29.690

2.  Pericardial disease in scleroderma (systemic sclerosis).

Authors:  J E McWhorter; E C LeRoy
Journal:  Am J Med       Date:  1974-10       Impact factor: 4.965

3.  Recommendations regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic measurements.

Authors:  D J Sahn; A DeMaria; J Kisslo; A Weyman
Journal:  Circulation       Date:  1978-12       Impact factor: 29.690

4.  Autonomic dysfunction in systemic sclerosis: time and frequency domain 24 hour heart rate variability analysis.

Authors:  C Ferri; M Emdin; D Giuggioli; C Carpeggiani; M Maielli; A Varga; C Michelassi; G Pasero; A L'Abbate
Journal:  Br J Rheumatol       Date:  1997-06

5.  Myocardial lesions of progressive systemic sclerosis. A cause of cardiac dysfunction.

Authors:  B H Bulkley; R L Ridolfi; W R Salyer; G M Hutchins
Journal:  Circulation       Date:  1976-03       Impact factor: 29.690

6.  Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee.

Authors: 
Journal:  Arthritis Rheum       Date:  1980-05

7.  The prevalence of conduction defects and cardiac arrhythmias in progressive systemic sclerosis.

Authors:  N K Roberts; W R Cabeen; J Moss; P J Clements; D E Furst
Journal:  Ann Intern Med       Date:  1981-01       Impact factor: 25.391

8.  Autoantibody to centromere (kinetochore) in scleroderma sera.

Authors:  Y Moroi; C Peebles; M J Fritzler; J Steigerwald; E M Tan
Journal:  Proc Natl Acad Sci U S A       Date:  1980-03       Impact factor: 11.205

9.  Ultrasonic videodensitometric analysis of two different models of left ventricular hypertrophy. Athlete's heart and hypertension.

Authors:  V Di Bello; R Pedrinelli; D Giorgi; A Bertini; L Talarico; M T Caputo; B Massimiliano; G Dell'Omo; M Paterni; C Giusti
Journal:  Hypertension       Date:  1997-04       Impact factor: 10.190

10.  Angina pectoris, myocardial infarction and sudden cardiac death with normal coronary arteries: a clinicopathologic study of 9 patients with progressive systemic sclerosis.

Authors:  B H Bulkley; P G Klacsmann; G M Hutchins
Journal:  Am Heart J       Date:  1978-05       Impact factor: 4.749

View more
  3 in total

1.  Myocardial perfusion defects in scleroderma detected by contrast-enhanced cardiovascular magnetic resonance.

Authors:  Nicolò Schicchi; Gianluca Valeri; Gianluca Moroncini; Giacomo Agliata; Luca Salvolini; Armando Gabrielli; Andrea Giovagnoni
Journal:  Radiol Med       Date:  2014-06-07       Impact factor: 3.469

2.  Systemic Sclerosis Portends Increased Risk of Conduction and Rhythm Abnormalities at Diagnosis and During Disease Course: A US Population-Based Cohort.

Authors:  Yasser A Radwan; Reto D Kurmann; Avneek S Sandhu; Edward A El-Am; Cynthia S Crowson; Eric L Matteson; Thomas G Osborn; Kenneth J Warrington; Rekha Mankad; Ashima Makol
Journal:  J Scleroderma Relat Disord       Date:  2021-07-28

3.  Identification of myocardial damage in systemic sclerosis: a nuclear cardiology approach.

Authors:  Kenichi Nakajima; Shinro Matsuo; Minoru Hasegawa; Seigo Kinuya; Kazuhiko Takehara
Journal:  Int J Rheumatol       Date:  2010-08-31
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.